Etanercept significantly slows radiographic progression of psoriatic and rheumatoid arthritis: PRERA Trial Dr. Kamal Kant Kohli11 Nov 2022 3:45 AM GMTGERMANY: According to research that was recently published in the journal, Rheumatology and Therapy, mean radiographic progression in patients with...
Lupin gets Health Canada nod for plaque psoriasis treatment Rymti Ruchika Sharma13 Sep 2022 8:49 AM GMTMumbai: Global pharma major, Lupin Limited, announced today that Health Canada has approved Rymti, its biosimilar to Enbrel (etanercept), for use in...
Add on Etanercept improves recovery and reduces steroids need in Stevens-Johnson syndrome Medha Baranwal29 May 2022 2:00 PM GMTChina: In Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) patients, an add-in of etanercept at the time of conventional therapy...
Etanercept lowers disease activity and helps patients achieve remission in RA Dr. Shravani Dali26 March 2022 3:30 AM GMTEtanercept is effective in Rheumatoid Arthritis according to a recent study published in the Springer. For rheumatoid arthritis (RA), the...
Pirfenidone induced Steven-Johnson syndrome/Toxic epidermal necrolysis: 1st case report Dr Manoj Kumar Nayak16 July 2021 3:30 AM GMTPirfenidone induced Steven-Johnson syndrome/Toxic epidermal necrolysis: 1st case report Pirfenidone is a novel orally administered drug used for...
Etanercept Effective in Re-Treatment of Juvenile Idiopathic Arthritis: Study MD Bureau31 May 2021 3:30 AM GMTJuvenile idiopathic arthritis (JIA) is the most common chronic inflammatory rheumatic disease in children and adolescents. A recent study suggests...
Etanercept in COVID19 patients: CDSCO Committee tells Lupin to submit revised phase 2 CT protocol Medical Dialogues Team9 March 2021 12:10 PM GMTNew Delhi: The Subject Expert Committee (SEC), functional under Central Drug Standard Organization (CDSCO), has recently suggested drug major Lupin...
Lupin reports net profit at Rs 211 crore in Q2 Ruchika Sharma7 Nov 2020 3:30 AM GMTNew Delhi: Drug firm Lupin has reported a consolidated net profit of Rs 211.02 crore for the quarter ended September 30, 2020 mainly on account of...
Lupin, Mylan launch arthritis drug Nepexto in Germany Ruchika Sharma27 Aug 2020 6:23 AM GMTThe product is available as an injectable in an easy-to-use pre- filled pen and a pre-filled syringe.
Lupin, Mylan get European nod to market Nepexto for treating arthritis, psoriasis Ruchika Sharma5 Jun 2020 6:38 AM GMTMumbai: Lupin Limited and Mylan N.V. have announced that the European Commission (EC) has granted marketing authorization for Nepexto®, a biosimilar...
